Figure_5.tif (85.44 kB)
Model of bladder cancer.
figure
posted on 2012-06-19, 00:48 authored by Joel R. Ho, Elodie Chapeaublanc, Lisa Kirkwood, Remy Nicolle, Simone Benhamou, Thierry Lebret, Yves Allory, Jennifer Southgate, François Radvanyi, Bruno GoudThe “FGFR3 model” of bladder cancer progression distinguishes a FGFR3-non-mutated tumor pathway and a FGFR3-mutated tumor pathway. Cis: Carcinoma in situ. Stages were defined by the 1997 TNM classification and grades by the 1973 World Health Organization classification (see Material and Methods for reference).